Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Angiography Devices Market Outlook (2023 to 2033)

The global angiography devices market is expected to reach a valuation of US$ 12,717.9 million in 2023. The expanding application and technology innovation scope is projected to be the market's primary growth drivers. The overall sales of angiography devices are projected to record a robust CAGR of 6.2% between 2023 and 2033, totaling around US$ 23,309.3 million by the end of 2033.

The conspicuous growth of the global healthcare industry's demand for accurate diagnosis and procedural equipment has positively influenced the consumption of angiography devices. Given the massive prevalence of cardiovascular diseases, the clamor for angiography devices is projected to rise further.

Medical and surgical technology advancements are assumed to contribute to the higher production of angiography devices. The precision of angiography devices may continue to influence their deployment by the world's leading medical organizations. Angiography devices, used to detect heart failures, may remain a significant trend in the global medical industry. As a result of this trend, the usage of angiography devices may grow exponentially, benefiting end-user well-being as well.

The high incidence of diseases such as cancer and CVDs, enhancing product approvals for sophisticated angiography techniques in the market, a substantial percentage of active research activities, burgeoning government and public-private investments, a growing amount of programs and initiatives, and high adoption of angiography devices due to the large angiography procedures performed globally all contribute to the market's development.

Report Attributes or Data Points Details
Global Angiography Devices Market Valuation in 2022 US$ 12,116.7 million
Estimated Global Market Share in 2023 US$ 12,717.9 million
Forecasted Global Market Size by 2033 US$ 23,309.3 million
Projected Global Market Growth Rate from 2023 to 2033 6.2% CAGR
Historical Market Growth Rate from 2018 to 2022 4.1% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Angiography Devices Demand Analysis (2018 to 2022) Vs. Market Outlook (2023 to 2033)

According to Future Market Insights, global demand for angiography devices is assumed to rise at a CAGR of 6.2% between 2023 and 2033, which compares favorably to a 4.1% CAGR from 2018 to 2022. The extensive use of angiography devices in cardiometabolic therapeutic interventions may be a key factor driving the growth of the global angiography devices market.

Furthermore, the emergence of new and upgraded products is expected to supplement the market for angiography devices. The devices, anticipated to be available in the vast bulk of hospitals, are also used to mitigate the incidence rate of cardiac diseases. As a result, demand for angiography devices is expected to continue for decades, boosting the market growth during the forecast period.

Investments in the healthcare sector are escalating. The angiography devices market is also witnessing a surge in investment from government and non-government organizations. The increment of healthcare infrastructure in several countries may provide lucrative business potential growth.

Furthermore, beneficial federal regulations for certification in various developed regions are expected to fuel global market expansion. A reversal in preference toward minimally invasive procedures is also a racing requirement for angiography systems. Furthermore, rapid advancements in angiography equipment are improving diagnostic methods and are estimated to generate market growth.

Which Factors are Restraining the Growth of the Angiography Devices Market?

If the device is damaged due to unforeseeable factors, the manufacturers do not reimburse or exchange the costs. Local medical facilities restrict the use of fragile angiography devices, lowering the diagnosis of cardiovascular diseases. The changing medical regulations necessitate the regular modernization of angiography devices, which confines the demand for existing or primitive devices and equipment. The high cost of angiography devices has resulted in the emergence of relatively cheap, inaccurate, and mendacious angiography equipment, which diversifies demand in the global angiography devices market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Region-wise Analysis

Factors Pushing the Angiography Devices Sales in North America

North America remained dominant in the global market in terms of revenue, accumulating a 37.2% share in 2022. Because of the higher prevalence of cardiac diseases, the United States and Canada are projected to augment angiography devices. According to the American Heart Association (AHA), 45 percent of the United States population may experience at least one heart-related problem. It also predicts that the costs of cardiovascular diseases may soar by 100% between 2016 and 2035. Furthermore, a sophisticated healthcare system allows for the wider utilization of new and advanced angiography devices.

The FDA approved it in March 2020, permitting it to be launched in the United States market. Furthermore, at the Radiological Society of North America (RSNA) 2020 virtual meeting, GE Healthcare debuted the Allia IGS 7 angiography system. The system employs artificial intelligence to strengthen the use of rotational angiography. North America is expected to hold a global market share of 33% in 2022.

Besides that, according to a research paper titled 'Cardiac Catheterization Risks and Complications,' in 2021, cardiac catheterization surgical operations on an annual basis in the United States were 1,000,000. Thus, there is a greater necessity for coronary angiography devices in the United States, further expanding the overall market in North America.

Regional Market Comparison Global Market Share in Percentage
North America 37.2%
Europe 28.1%

How Growth May Unfold in the Asia Pacific Angiography Devices Market?

Asia Pacific is anticipated to grow substantially due to a spike in the volume of CVD cases, as well as greater investment in the region's healthcare system, which may result in the accessibility of necessary medical facilities. As per FMI, an average CAGR of 6% is anticipated for the Asia Pacific market.

In comparison to cardiac catheterization, Coronary Angiography has very elevated accuracy in detecting patients with coronary heart disease. As a result, there is an increase in demand for Coronary Angiography Devices in this region.

The Japanese administration's favorable reimbursement policies to promote technological breakthroughs are aiding and abetting the region's growth. In countries such as South Korea, Brazil, and India, the regulatory environment is less stringent, creating an intriguing opportunity for global companies to establish a presence in these markets. China is consolidating to improve the quality of this equipment. Rising imports from leading market players such as GE Healthcare, Siemens Healthcare, and Koninklijke Philips N.V. are propelling the China angiography market forward.

Regional Market Comparison Global Market Share in Percentage
United States 34.1%
Germany 8.2%
Japan 8.3%

Growth in the Europe Angiography Devices Market

The Europe market is anticipated to register a CAGR of around 5.2% between 2022 and 2032. Burgeoning minimally invasive surgical interventions, increased emphasis on research and development capabilities in medical devices and on the adoption of advanced healthcare technologies, an increase in robotic-assisted surgical procedures, and rising expenditure on healthcare infrastructure development are the key factors driving the growth of the market in this region.

Furthermore, in Europe, the unhealthy lifestyle of the working segment of society may cause a spike in heart ailments, inciting the growth of the angiography devices market. Europe held a global market share of 28.1% in 2022.

Regional Markets CAGR (2023 to 2033)
United Kingdom 5.9%
China 8.3%
India 7.7%
Australia 5%

Category-wise Analysis

MRA Segment to Witness Key Growth

Based on the device, MRA is anticipated to be the fastest-growing technology in the diagnosis of heart disease because of its minimal radiation exposure. MRA can acquire images in any anatomical plane with fantastic soft tissue contrast in 3D. The advent of 3.0T MR imaging has greatly improved the diagnosis of coronary artery disease. These factors are said to boost segment growth as well.

In 2019, the diagnostic application dominated the market. CTA and MRA advancements provide useful information not only in cardiology but also in neurology, such as cerebral aneurysms, acute stroke, brain arteriovenous malformation, dural arteriovenous fistula, suspected cerebral vasculitis, and occlusive diseases.

Category By Procedure
Top Segment Coronary Angiography
Market Share in Percentage 48.7%
Category By End User
Top Segment Hospitals and Surgical Centers
Market Share in Percentage 61.1%

Hospitals and Surgical segment to augment the market growth

Historically, based on the end-users segment, the hospitals, and surgical centers segment occupied the dominant share of the global market. This segment's growth can be attributed to the wide range of patients diagnosed and treated in hospitals, hospitals' high purchasing capacity for advanced technologies, the enormous percentage of diagnostic and therapeutic angiographic procedures, and growing recognition of the effects of timely disease diagnosis.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

The Start-up Ecosystem: How Key Players Are Opening Frontiers for Future Growth?

Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,

Inorbvict Healthcare India Private Limited is a private company founded on August 21, 2014. It is headquartered in Pune, Maharashtra, India. They recently introduced a low-cost Angiography System to the market.

Who are the Leading Players in Angiography Devices Market?

Some leading angiography device manufacturers include Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Cordis Corporation, Shimadzu Corporation, and Siemens Healthcare.

These key angiography device providers are adopting strategies, such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc., to increase their sales and gain a competitive edge in the global angiography devices market. For instance,

  • In November 2021, Royal Philips unveiled its perception for interventional medicine by incorporating its breakthrough spectral CT imaging technology into a hybrid Angio CT suite. Philips hopes to give interventionalists immediate table-side access to these two key imaging modalities by combining the company's unique Spectral CT 7500 system and their Image-Guided Therapy System - Azurion with FlexArm in a single interventional suite solution.
  • GE Healthcare released its latest product, the ‘Discovery IG 740 mobile angiography system,’ in April 2022. The untethered Discovery IGS 740 provides incredible room design and sitting flexibility. With Discovery's rail-free design and flexible wide-bore C-arm positioning, users can practice exceptional comfort and control. Furthermore, its large detector covers large anatomies in both 2D and 3D.

Report Scope

Report Attribute Details
Growth Rate CAGR of 6.2% from 2023 to 2033
Market Value in 2023 US$ 12,717.9 million
Market Value in 2033 US$ 23,309.3 million
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Device
  • Procedure
  • End Use
  • Indication
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa
Key Countries Profiled
  • United States
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel
Key Companies Profiled
  • Abbott Vascular (Abbott Laboratories)
  • Toshiba Medical Systems Corporation
  • Royal Philips Electronics
  • GE Healthcare
  • Medtronic
  • Cordis Corporation
  • Shimadzu Corporation
  • Siemens Healthcare.
Customization Available Upon Request

Key Segments Covered in the Angiography Devices Market Report

By Device:

  • Magnetic Resonance Angiography (MRA) Devices
  • Computed Tomography Angiography (CTA) Devices
  • Conventional Angiography Devices
  • Digital Subtraction Angiography (DSA) Devices
  • Catheter Angiography Devices
  • Coronary Angiography Devices
  • Other Angiography Devices

By Procedure:

  • Coronary Angiography
  • Pulmonary Angiography
  • Cerebral Angiography
  • Extremity Angiography
  • Renal Angiography

By End User:

  • Hospitals and Surgical Centers
  • Diagnostics Centers
  • Academic and Research Institutes

By Indication:

  • Coronary Artery Disease (CAD)
  • Congenital Heart Disease
  • Congestive Heart Failure
  • Kidney Disorders
  • Other Indications

By Region:

  • North America Market
  • Latin America Market
  • Europe Market
  • East Asia Market
  • South Asia and Pacific Market
  • The Middle East & Africa (MEA) Market

Frequently Asked Questions

What is the Growth Potential of the Angiography Devices Market?

The growth potential of the angiography devices market is 6.2% CAGR through 2033.

What is the market value evaluation for the year 2033?

The market is expected to be valued at US$ 23,309.3 million by 2033.

Which Region Enjoys Market Monopoly?

North America enjoys monopoly in the angiography devices market.

Which are the Key Asian Countries in the Angiography Devices Market?

India and China dominate the Asian market.

Who are the Key Angiography Devices Market Players?

Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, and Royal Philips Electronics are key market players.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Device, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Device, 2023 to 2033

        5.3.1. Magnetic Resonance Angiography (MRA)

        5.3.2. Computed Tomography Angiography (CTA)

        5.3.3. Conventional

        5.3.4. Digital Subtraction Angiography (DSA)

        5.3.5. Catheter

        5.3.6. Coronary

        5.3.7. Other

    5.4. Y-o-Y Growth Trend Analysis By Device, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Device, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Procedure, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Procedure, 2023 to 2033

        6.3.1. Coronary Angiography

        6.3.2. Pulmonary Angiography

        6.3.3. Cerebral Angiography

        6.3.4. Extremity Angiography

        6.3.5. Renal Angiography

    6.4. Y-o-Y Growth Trend Analysis By Procedure, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Procedure, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        7.3.1. Hospitals and Surgical Centres

        7.3.2. Diagnostics Centres

        7.3.3. Academic and Research Institutes

    7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033

        8.3.1. Coronary Artery Disease (CAD)

        8.3.2. Congenital Heart Disease

        8.3.3. Congestive Heart Failure

        8.3.4. Kidney Disorders

        8.3.5. Other Indications

    8.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Device

        10.2.3. By Procedure

        10.2.4. By End User

        10.2.5. By Indication

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Device

        10.3.3. By Procedure

        10.3.4. By End User

        10.3.5. By Indication

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Device

        11.2.3. By Procedure

        11.2.4. By End User

        11.2.5. By Indication

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Device

        11.3.3. By Procedure

        11.3.4. By End User

        11.3.5. By Indication

    11.4. Key Takeaways

12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UK

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Device

        12.2.3. By Procedure

        12.2.4. By End User

        12.2.5. By Indication

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Device

        12.3.3. By Procedure

        12.3.4. By End User

        12.3.5. By Indication

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Device

        13.2.3. By Procedure

        13.2.4. By End User

        13.2.5. By Indication

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Device

        13.3.3. By Procedure

        13.3.4. By End User

        13.3.5. By Indication

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Device

        14.2.3. By Procedure

        14.2.4. By End User

        14.2.5. By Indication

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Device

        14.3.3. By Procedure

        14.3.4. By End User

        14.3.5. By Indication

    14.4. Key Takeaways

15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Device

        15.2.3. By Procedure

        15.2.4. By End User

        15.2.5. By Indication

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Device

        15.3.3. By Procedure

        15.3.4. By End User

        15.3.5. By Indication

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Device

        16.2.3. By Procedure

        16.2.4. By End User

        16.2.5. By Indication

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Device

        16.3.3. By Procedure

        16.3.4. By End User

        16.3.5. By Indication

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Device

            17.1.2.2. By Procedure

            17.1.2.3. By End User

            17.1.2.4. By Indication

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Device

            17.2.2.2. By Procedure

            17.2.2.3. By End User

            17.2.2.4. By Indication

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Device

            17.3.2.2. By Procedure

            17.3.2.3. By End User

            17.3.2.4. By Indication

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Device

            17.4.2.2. By Procedure

            17.4.2.3. By End User

            17.4.2.4. By Indication

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Device

            17.5.2.2. By Procedure

            17.5.2.3. By End User

            17.5.2.4. By Indication

    17.6. UK

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Device

            17.6.2.2. By Procedure

            17.6.2.3. By End User

            17.6.2.4. By Indication

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Device

            17.7.2.2. By Procedure

            17.7.2.3. By End User

            17.7.2.4. By Indication

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Device

            17.8.2.2. By Procedure

            17.8.2.3. By End User

            17.8.2.4. By Indication

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Device

            17.9.2.2. By Procedure

            17.9.2.3. By End User

            17.9.2.4. By Indication

    17.10. Poland

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Device

            17.10.2.2. By Procedure

            17.10.2.3. By End User

            17.10.2.4. By Indication

    17.11. Russia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Device

            17.11.2.2. By Procedure

            17.11.2.3. By End User

            17.11.2.4. By Indication

    17.12. Czech Republic

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Device

            17.12.2.2. By Procedure

            17.12.2.3. By End User

            17.12.2.4. By Indication

    17.13. Romania

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Device

            17.13.2.2. By Procedure

            17.13.2.3. By End User

            17.13.2.4. By Indication

    17.14. India

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Device

            17.14.2.2. By Procedure

            17.14.2.3. By End User

            17.14.2.4. By Indication

    17.15. Bangladesh

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Device

            17.15.2.2. By Procedure

            17.15.2.3. By End User

            17.15.2.4. By Indication

    17.16. Australia

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Device

            17.16.2.2. By Procedure

            17.16.2.3. By End User

            17.16.2.4. By Indication

    17.17. New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Device

            17.17.2.2. By Procedure

            17.17.2.3. By End User

            17.17.2.4. By Indication

    17.18. China

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Device

            17.18.2.2. By Procedure

            17.18.2.3. By End User

            17.18.2.4. By Indication

    17.19. Japan

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Device

            17.19.2.2. By Procedure

            17.19.2.3. By End User

            17.19.2.4. By Indication

    17.20. South Korea

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Device

            17.20.2.2. By Procedure

            17.20.2.3. By End User

            17.20.2.4. By Indication

    17.21. GCC Countries

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Device

            17.21.2.2. By Procedure

            17.21.2.3. By End User

            17.21.2.4. By Indication

    17.22. South Africa

        17.22.1. Pricing Analysis

        17.22.2. Market Share Analysis, 2022

            17.22.2.1. By Device

            17.22.2.2. By Procedure

            17.22.2.3. By End User

            17.22.2.4. By Indication

    17.23. Israel

        17.23.1. Pricing Analysis

        17.23.2. Market Share Analysis, 2022

            17.23.2.1. By Device

            17.23.2.2. By Procedure

            17.23.2.3. By End User

            17.23.2.4. By Indication

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Device

        18.3.3. By Procedure

        18.3.4. By End User

        18.3.5. By Indication

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Abbott Vascular (Abbott Laboratories)

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

                19.1.1.5.2. Product Strategy

                19.1.1.5.3. Channel Strategy

        19.1.2. Toshiba Medical Systems Corporation

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

                19.1.2.5.2. Product Strategy

                19.1.2.5.3. Channel Strategy

        19.1.3. Royal Philips Electronics

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

                19.1.3.5.2. Product Strategy

                19.1.3.5.3. Channel Strategy

        19.1.4. GE Healthcare

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

                19.1.4.5.2. Product Strategy

                19.1.4.5.3. Channel Strategy

        19.1.5. Medtronic

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

                19.1.5.5.2. Product Strategy

                19.1.5.5.3. Channel Strategy

        19.1.6. Cordis Corporation

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

                19.1.6.5.2. Product Strategy

                19.1.6.5.3. Channel Strategy

        19.1.7. Shimadzu Corporation

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

                19.1.7.5.2. Product Strategy

                19.1.7.5.3. Channel Strategy

        19.1.8. Siemens Healthcare.

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

                19.1.8.5.2. Product Strategy

                19.1.8.5.3. Channel Strategy

        19.1.9. Canon Medical Systems

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

                19.1.9.5.2. Product Strategy

                19.1.9.5.3. Channel Strategy

        19.1.10. St. Jude Medical Inc.

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

                19.1.10.5.2. Product Strategy

                19.1.10.5.3. Channel Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Cardiovascular Prosthetic Devices Market

Published : September 2022

Explore Healthcare Insights

View Reports

Angiography Devices Market